Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022025276 - THERAPEUTIC AGENT FOR NERVE DISFUNCTION

Publication Number WO/2022/025276
Publication Date 03.02.2022
International Application No. PCT/JP2021/028420
International Filing Date 30.07.2021
IPC
A61K 35/28 2015.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
A61P 25/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
CPC
A61K 35/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
Applicants
  • ニューロテックメディカル株式会社 NEUROTECH MEDICAL CO., LTD. [JP]/[JP]
Inventors
  • 貴宝院 永稔 KIHOIN Nagatoshi
  • 岡田 邦彦 OKADA Kunihiko
Agents
  • 新山 雄一 NIIYAMA Yuichi
  • 来間 清志 KURUMA Kiyoshi
Priority Data
2020-13091131.07.2020JP
Publication Language Japanese (ja)
Filing Language Japanese (JA)
Designated States
Title
(EN) THERAPEUTIC AGENT FOR NERVE DISFUNCTION
(FR) AGENT THÉRAPEUTIQUE DE NEUROPATHIE
(JA) 神経障害の治療剤
Abstract
(EN) The present invention addresses the problem of providing a therapeutic agent containing mesenchymal stem cells, which is more effective for the treatment of a nerve disfunction. The present invention provides a therapeutic agent for a nerve disfunction. The therapeutic agent is a preparation for intravenous administration which contains mesenchymal stem cells and/or cells capable of being differentiated into mesenchymal stem cells, and is used in combination with the application of a stimulus to nerves in a patient, in which the application of a stimulus is carried out during a time period between a time point at which the administration of the therapeutic agent is not carried out yet and a time point at which 6 hours has passed after the administration of the therapeutic agent.
(FR) L'invention a pour objet de fournit un agent thérapeutique comprenant des cellules souches mésenchymateuses qui révèle une meilleure efficacité dans le traitement de la neuropathie. Plus précisément, l'invention fournit un agent thérapeutique de neuropathie. Lequel agent thérapeutique consiste en une préparation administrée par voie intraveineuse qui contient des cellules souches mésenchymateuses et/ou des cellules permettant une différenciation en cellules souches mésenchymateuses, et peut être mis en œuvre de manière combinée avec une application de stimulus vis-à-vis des nerfs d'un patient. Cette application de stimulus peut être effectuée jusqu'à 6 heures avant et après administration dudit agent thérapeutique.
(JA) 本発明の課題は、神経障害の治療により有効な、間葉系幹細胞含有治療剤を提供することである。 本発明は、神経障害の治療剤であって、前記治療剤は、間葉系幹細胞及び/又は間葉系幹細胞に分化可能な細胞を含む静脈内投与製剤であり、かつ、患者の神経への刺激付与と併用され、前記刺激付与は、前記治療剤の投与前から投与後6時間までに行われる、治療剤を提供する。
Related patent documents
Latest bibliographic data on file with the International Bureau